Page 301 - Read Online

Ghosh et al. Neuroimmunol Neuroinflammation 2018;5:38 I http://dx.doi.org/10.20517/2347-8659.2018.28 Page 11 of 11

emic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999;52:280-4.
28. Mehta A, Mahale R, Buddaraju K, Majeed A, Sharma S, Javali M, Acharya P, Srinivasa R. Intravenous thrombolysis for acute ischemic
stroke: review of 97 patients. J Neurosci Rural Pract 2017;8:38-43.
29. Liu M, Pan Y, Zhou L, Wang Y. Predictors of post-thrombolysis symptomatic intracranial hemorrhage in Chinese patients with acute
ischemic stroke. PLoS One 2017;12:e0184646.
30. Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, Grotta J, Howard G, Kaste M,
Koga M, von Kummer R, Lansberg M, Lindley RI, Murray G, Olivot JM, Parsons M, Tilley B, Toni D, Toyoda K, Wahlgren N, Wardlaw J,
Whiteley W, del Zoppo GJ, Baigent C, Sandercock P, Hacke W; Stroke Thrombolysis Trialists’ Collaborative Group. Effect of treatment
delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of
individual patient data from randomised trials. Lancet 2014;384:1929-35.
31. VanGilder RL, Davidov DM, Stinehart KR, Huber JD, Turner RC, Wilson KS, Haney E, Davis SM, Chantler PD, Theeke L, Rosen CL,
Crocco TJ, Gutmann L, Barr TL. C-reactive protein and long-term ischemic stroke prognosis. J Clin Neurosci 2014;21:547-53.
32. Winbeck K, Poppert H, Etgen T, Conrad B, Sander D. Prognostic relevance of early serial C-reactive protein measurements after first
ischemic stroke. Stroke 2002;33:2459-64.
33. Song IU, Kim YD, Kim JS, Lee KS, Chung SW. Can high-sensitivity C-reactive protein and plasma homocysteine levels independently
predict the prognosis of patients with functional disability after first-ever ischemic stroke? Eur Neurol 2010;64:304-10.
34. Rothwell PM, Howard SC, Power DA, Gutnikov SA, Algra A, van Gijn J, Clark TG, Murphy MF, Warlow CP. Fibrinogen concentration
and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke. Stroke
2004;35:2300-5.
35. Lee SJ, Hong JM, Lee SE, Kang DR, Ovbiagele B, Demchuk AM, Lee JS. Association of fibrinogen level with early neurological dete-
rioration among acute ischemic stroke patients with diabetes. BMC Neurol 2017;17:101.
36. Huang X, Moreton FC, Kalladka D, Cheripelli BK, MacIsaac R, Tait RC, Muir KW. Coagulation and fibrinolytic activity of tenecteplase
and alteplase in acute ischemic stroke. Stroke 2015;46:3543-6.
37. Ill-Raga G, Palomer E, Ramos-Fernández E, Guix FX, Bosch-Morató M, Guivernau B, Tajes M, Valls-Comamala V, Jiménez-Conde
J, Ois A, Pérez-Asensio F, Reyes-Navarro M, Caballo C, Gil-Gómez G, Lopez-Vilchez I, Galan AM, Alameda F, Escolar G, Opazo C,
Planas AM, Roquer J, Valverde MA, Muñoz FJ. Fibrinogen nitrotyrosination after ischemic stroke impairs thrombolysis and promotes
neuronal death. Biochim Biophys Acta 2015;1852:421-8.
38. Zi WJ, Shuai J. Plasma D-dimer levels are associated with stroke subtypes and infarction volume in patients with acute ischemic stroke.
PLoS One 2014;9:e86465.
39. Kim TW, Song IU, Chung SW. Prognostic value of serum D-Dimer in noncardioembolic ischemic stroke. Can J Neurol Sci
2017;44:404-9.
40. Anand N, Stead LG. Neuron-specific enolase as a marker for acute ischemic stroke: a systematic review. Cerebrovasc Dis 2005;20:213-
9.
41. Zaheer S, Beg M, Rizvi I, Islam N, Ullah E, Akhtar N. Correlation between serum neuron specific enolase and functional neurological
outcome in patients of acute ischemic stroke. Ann Indian Acad Neurol 2013;16:504-8.